Point72 Asset Management’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,573,700
| Closed | -$60.8M | – | 2002 |
|
|
2023
Q4 | $60.8M | Buy |
2,573,700
+143,776
| +6% | +$3.4M | 0.15% | 171 |
|
|
2023
Q3 | $36.2M | Buy |
+2,429,924
| New | +$36.2M | 0.11% | 232 |
|
|
2023
Q2 | – | Sell |
-20,597
| Closed | -$180K | – | 2296 |
|
|
2023
Q1 | $180K | Buy |
+20,597
| New | +$180K | ﹤0.01% | 1054 |
|
|
2022
Q3 | – | Sell |
-350,000
| Closed | -$1.03M | – | 1439 |
|
|
2022
Q2 | $1.03M | Buy |
+350,000
| New | +$1.03M | ﹤0.01% | 836 |
|
|
2022
Q1 | – | Sell |
-681,401
| Closed | -$2.3M | – | 1344 |
|
|
2021
Q4 | $2.3M | Buy |
+681,401
| New | +$2.3M | 0.01% | 749 |
|
|
2020
Q3 | – | Sell |
-576,638
| Closed | -$2.01M | – | 1077 |
|
|
2020
Q2 | $2.01M | Buy |
+576,638
| New | +$2.01M | 0.01% | 555 |
|
|
2019
Q4 | – | Sell |
-3,160,600
| Closed | -$16.2M | – | 1261 |
|
|
2019
Q3 | $16.2M | Sell |
3,160,600
-738,030
| -19% | -$3.78M | 0.1% | 243 |
|
|
2019
Q2 | $27.9M | Buy |
+3,898,630
| New | +$27.9M | 0.15% | 158 |
|
|
2019
Q1 | – | Sell |
-219,715
| Closed | -$1.73M | – | 1161 |
|
|
2018
Q4 | $1.73M | Buy |
219,715
+145,518
| +196% | +$1.15M | 0.01% | 643 |
|
|
2018
Q3 | $822K | Buy |
+74,197
| New | +$822K | ﹤0.01% | 709 |
|
|
2016
Q2 | – | Sell |
-843,800
| Closed | -$1.14M | – | 827 |
|
|
2016
Q1 | $1.14M | Sell |
843,800
-191,488
| -18% | -$258K | 0.01% | 549 |
|
|
2015
Q4 | $1.75M | Hold |
1,035,288
| – | – | 0.01% | 524 |
|
|
2015
Q3 | $2.01M | Buy |
1,035,288
+450,000
| +77% | +$873K | 0.02% | 512 |
|
|
2015
Q2 | $1.57M | Hold |
585,288
| – | – | 0.01% | 542 |
|
|
2015
Q1 | $4.05M | Buy |
585,288
+14,200
| +2% | +$98.3K | 0.03% | 431 |
|
|
2014
Q4 | $5.61M | Buy |
+571,088
| New | +$5.61M | 0.04% | 389 |
|